MedTrace Logo

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

NCT00012558 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5000

Last updated 2007-05-04

No results posted yet for this study

Summary

A long-term study of current treatments for bipolar disorder, including medications and psychosocial therapies.

Conditions

Interventions

DRUG

lithium

DRUG

valproate

DRUG

bupropion

DRUG

paroxetine

DRUG

lamotrigine

DRUG

risperidone

DRUG

inositol

DRUG

tranylcypromine

BEHAVIORAL

Cognitive Behavioral Therapy

BEHAVIORAL

Family-focused Therapy

BEHAVIORAL

Interpersonal and Social Rhythms Therapy

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    lead NIH

Principal Investigators

  • Gary Sachs, M.D. · Massachusetts General Hospital

  • Michael Thase, M.D. · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-09-30
Completion
2005-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00012558 on ClinicalTrials.gov